0001209191-23-017707.txt : 20230309 0001209191-23-017707.hdr.sgml : 20230309 20230309210445 ACCESSION NUMBER: 0001209191-23-017707 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230307 FILED AS OF DATE: 20230309 DATE AS OF CHANGE: 20230309 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RATOFF STEVEN B CENTRAL INDEX KEY: 0001054941 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36306 FILM NUMBER: 23721417 MAIL ADDRESS: STREET 1: 5291 N CAMINO SW CITY: TUSCON STATE: AZ ZIP: 85718 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: EAGLE PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000827871 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 TICE BOULEVARD, SUITE 315 CITY: WOODCLIFF LAKE STATE: NJ ZIP: 07677 BUSINESS PHONE: 201-326-5300 MAIL ADDRESS: STREET 1: 50 TICE BOULEVARD, SUITE 315 CITY: WOODCLIFF LAKE STATE: NJ ZIP: 07677 FORMER COMPANY: FORMER CONFORMED NAME: EAGLE PHARMACEUTICALS INC DATE OF NAME CHANGE: 19880120 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-03-07 0 0000827871 EAGLE PHARMACEUTICALS, INC. EGRX 0001054941 RATOFF STEVEN B C/O EAGLE PHARMACEUTICALS, INC. 50 TICE BLVD., SUITE 315 WOODCLIFF LAKE NJ 07677 1 0 0 0 Stock Option (right to buy) 26.00 2023-03-07 4 A 0 16253 0.00 A 2033-03-07 Common Stock 16253 16253 D The option fully vests on March 7, 2024, subject to the Reporting Person's continuous service with the Issuer as of the vesting date. /s/ Scott Tarriff, Attorney-in-Fact 2023-03-09